Skip to main content

Cefotaxime Sodium Injection

Last Updated: September 7, 2022
Status: Current

Products Affected - Description
    • Claforan injection, Baxter, 1 gram/50 mL, frozen premixed bag, 24 count, NDC 00039-0038-05 - discontinued
    • Claforan injection, Baxter, 2 gram/50 mL, frozen premixed bag, 24 count, NDC 00039-0039-05 - discontinued
    • Cefotaxime Sodium powder for solution for injection, Hikma, 1 gram, vial, 25 count, NDC 00143-9931-25
    • Cefotaxime Sodium powder for solution for injection, Hikma, 10 gram, vial, 1 count, NDC 00143-9935-01
    • Cefotaxime Sodium powder for solution for injection, Hikma, 2 gram, vial, 25 count, NDC 00143-9933-25
    • Cefotaxime Sodium powder for solution for injection, Hikma, 500 mg, vial, 10 count, NDC 00143-9930-10
Reason for the Shortage
    • Hospira has discontinued Claforan. Sanofi-Aventis manufactured Claforan for Hospira and is no longer making the product.
    • Hikma is not currently marketing cefotaxime injection.
Available Products
    • There is insufficient supply for usual ordering

Estimated Resupply Dates

    • Provepharm is temporarily importing cefotaxime 1 gram and 2 gram vials.

Alternative Agents & Management

    • FDA is allowing temporary importation of cefotaxime 1 gram and 2 gram vials from Provepharm and its distributor Direct Success. The cefotaxime is supplied by SteriMax from Canada. Customers can contact Direct Success at 1-877-404-3338 to place orders. See https://www.fda.gov/media/152806/download for details.

Updated

Updated September 7, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created July 31, 2013 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.